-
Weekly Roundup: Dubious Controversy, Outrageous Pricing and Angels in South Africa
Among the week's highlights (and lowlights): Grameen Foundation and Muhammad Yunus make an unwelcome entrance into U.S. presidential politics, Mylan Pharmaceuticals defends itself from price-gouging accusations, and a business angel network launches in South Africa.
- Categories
- Education, Health Care, Investing, Social Enterprise
